Cite
HARVARD Citation
Todisco, E. et al. (2020). Efficacy of venetoclax based salvage chemotherapy followed by "Minimal Residual Disease driven"-venetoclax maintenance therapy post-allotransplant in a young patient with high risk primary refractory acute myeloid leukemia. Leukemia & lymphoma. 61 (9), pp. 2277-2279. [Online].